Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 3Neoplasm Metastasis 2Prostatic Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Gliosarcoma 1Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

Gemcitabine 43Paclitaxel 37pembrolizumab 36Nivolumab 32Docetaxel 30Capecitabine 29Bevacizumab 29Oxaliplatin 28Fluorouracil 28Cisplatin 26Leucovorin 24Cyclophosphamide 23Irinotecan 21Radiosurgery 20Carboplatin 20aldesleukin 19Cetuximab 19Interleukin-2 16fludarabine phosphate 15fludarabine 15Pemetrexed 15Trastuzumab 14Magnetic Resonance Spectroscopy 14Ipilimumab 14Fulvestrant 14130-nm albumin-bound paclitaxel 14Prednisone 13Everolimus 13Radiotherapy 12Panitumumab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Neoplasm Metastasis × Quality of Life × Clear all
NCT00814463 2019-02-26

Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases

Duke University

Phase 2 Terminated
1 enrolled 6 charts
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT00910039 2014-09-29

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Case Comprehensive Cancer Center

Phase 2 Terminated
14 enrolled 12 charts
CNS

Brain Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡